scholarly article | Q13442814 |
P50 | author | Diego Centonze | Q42218235 |
Giorgio Bernardi | Q110496108 | ||
P2093 | author name string | Cristina Grande | |
Paolo Calabresi | |||
Diego Centonze | |||
Ana B Martin | |||
Antonio Pisani | |||
Paolo Gubellini | |||
Rosario Moratalla | |||
Emilia Saulle | |||
Nancy Pavón | |||
P2860 | cites work | Addiction and the brain: The neurobiology of compulsion and its persistence | Q22337278 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 | Q24313045 | ||
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor | Q24321094 | ||
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes | Q24560472 | ||
Addiction, dopamine, and the molecular mechanisms of memory | Q28142501 | ||
Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive | Q28217938 | ||
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain | Q28276882 | ||
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum | Q28576571 | ||
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses | Q28585702 | ||
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons | Q28589923 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Molecular basis of long-term plasticity underlying addiction | Q29620539 | ||
Structure and function of dopamine receptors | Q33828020 | ||
Inhibitory control of neostriatal projection neurons by GABAergic interneurons | Q33861738 | ||
Pathophysiology of the basal ganglia in Parkinson's disease. | Q34070859 | ||
Catching up on schizophrenia: natural history and neurobiology | Q34122141 | ||
Dopaminergic control of synaptic plasticity in the dorsal striatum | Q34206258 | ||
Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses | Q36054269 | ||
In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation | Q36247620 | ||
Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor | Q37056920 | ||
Dopamine receptor subtypes colocalize in rat striatonigral neurons | Q37270387 | ||
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene | Q37511116 | ||
Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 | ||
Modulation of long-term synaptic plasticity at excitatory striatal synapses | Q41648201 | ||
Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates | Q41701358 | ||
Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 | ||
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons | Q42484453 | ||
Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal | Q42521545 | ||
Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype | Q42528574 | ||
Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro | Q43517989 | ||
A cellular mechanism of reward-related learning. | Q43729267 | ||
Behavioral characterization of dopamine D5 receptor null mutant mice | Q43755274 | ||
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors | Q43854201 | ||
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum | Q44051643 | ||
Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances | Q46110140 | ||
Striatal excitatory amino acid receptor subunit expression in the D1A-dopamine receptor-deficient mouse | Q47738070 | ||
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. | Q48257417 | ||
Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum | Q48446136 | ||
Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release | Q48502195 | ||
D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade | Q48589850 | ||
NADPH-diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities | Q48792888 | ||
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons | Q48890601 | ||
Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. | Q48967375 | ||
Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum | Q49155446 | ||
Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum | Q51652804 | ||
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels. | Q52079554 | ||
Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. | Q52165392 | ||
Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo. | Q52166095 | ||
Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats. | Q54052206 | ||
Hybrid hybridomas and their use in immunohistochemistry | Q59087466 | ||
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity | Q63256021 | ||
Unilateral dopamine denervation blocks corticostriatal LTP | Q73280384 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
striatum | Q1319792 | ||
synaptic plasticity | Q1551556 | ||
Dopamine receptor D5 | Q21494359 | ||
Dopamine receptor D1 | Q21984178 | ||
P304 | page(s) | 8506-8512 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity | |
P478 | volume | 23 |
Q30474975 | A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling |
Q36940413 | A molecular switch for induction of long-term depression of corticostriatal transmission |
Q42497036 | A possible mechanism for the effect of modifiable lateral inhibition in the striatum on the selection of conditioned reflex motor responses |
Q28573319 | A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum |
Q39398723 | Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment |
Q90989489 | Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators |
Q89458217 | An Assessment between D1 Receptor Agonist and D2 receptor Antagonist into the Ventral Tegmental Area on Conditioned Place Preference and Locomotor Activity |
Q34452254 | Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorder. |
Q49361175 | Basal ganglia mechanisms in action selection, plasticity, and dystonia. |
Q90481704 | CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes |
Q34166461 | Changes in striatal dopamine release associated with human motor-skill acquisition |
Q88803206 | Cholinergic modulation of striatal microcircuits |
Q45072843 | Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. |
Q36900126 | Combining Dopaminergic Facilitation with Robot-Assisted Upper Limb Therapy in Stroke Survivors: A Focused Review |
Q37342898 | Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys |
Q36981184 | Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization |
Q37883081 | Computational models of reinforcement learning: the role of dopamine as a reward signal |
Q33756951 | Convergent evidence for abnormal striatal synaptic plasticity in dystonia |
Q34397299 | D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. |
Q34712560 | Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy |
Q36122543 | Differential CaMKII regulation by voltage-gated calcium channels in the striatum |
Q45968734 | Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. |
Q39872112 | Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells |
Q47666546 | Differential effects of acute administration of SCH-23390, a D₁ receptor antagonist, and of ethanol on swimming activity, anxiety-related responses, and neurochemistry of zebrafish |
Q35622636 | Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin |
Q30583673 | Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior |
Q48590755 | Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity |
Q30479694 | Distribution of D1 and D5 dopamine receptors in the primate and rat basolateral amygdala. |
Q28570291 | Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking |
Q34956828 | Dopamine D1 and D2 receptor family contributions to modafinil-induced wakefulness |
Q37250220 | Dopamine D1 and D5 receptors are localized to discrete populations of interneurons in primate prefrontal cortex |
Q41938830 | Dopamine D1 receptor inhibition of NMDA receptor currents mediated by tyrosine kinase-dependent receptor trafficking in neonatal rat striatum |
Q38868116 | Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons |
Q33709567 | Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression |
Q38062799 | Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity |
Q48317923 | Dopamine D2 receptor-dependent modulation of striatal NO synthase activity |
Q28582297 | Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release |
Q47178205 | Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease |
Q35545020 | Dopamine receptors and Parkinson's disease |
Q46095844 | Dopamine reduction of GABA currents in striatal medium-sized spiny neurons is mediated principally by the D(1) receptor subtype |
Q37592345 | Dystonia as a network disorder: what is the role of the cerebellum? |
Q30437527 | Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice |
Q42426464 | Electrical stimulation of the hippocampal fimbria facilitates neuronal nitric oxide synthase activity in the medial shell of the rat nucleus accumbens: Modulation by dopamine D1 and D2 receptor activation |
Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
Q36797973 | From dopaminergic genes to psychiatric disorders |
Q82029286 | Functional neurochemistry of the basal ganglia |
Q37872232 | Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease |
Q26783258 | Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3) |
Q90394686 | Histamine-induced plasticity and gene expression in corticostriatal pathway under hyperammonemia |
Q21558394 | How may the basal ganglia contribute to auditory categorization and speech perception? |
Q42028032 | Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity |
Q46166208 | Importance of D(1) receptors for associative components of amphetamine-induced behavioral sensitization and conditioned activity: a study using D(1) receptor knockout mice. |
Q30440985 | Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice. |
Q35955621 | Intrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion |
Q27687666 | Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration? |
Q36959855 | Mechanisms of disease: basic-research-driven investigations in humans--the case of hyperkinetic disorders |
Q30476813 | Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects |
Q88425933 | Modulatory effect of dopamine receptor 5 on the neurosecretory Dahlgren cells of the olive flounder, Paralichthys olivaceus |
Q37628212 | Motor cortex-evoked activity in reciprocal muscles is modulated by reward probability |
Q38136650 | Motor cortical plasticity in Parkinson's disease. |
Q46881179 | Motor-skill learning-associated gene regulation in the striatum: effects of cocaine |
Q24602643 | Neurogenetics and pharmacology of learning, motivation, and cognition |
Q53427789 | Nonequivalent modulation of corticospinal excitability by positive and negative outcomes. |
Q34470248 | Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis |
Q28742022 | Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons |
Q28084395 | Parkinson's disease as a result of aging |
Q41831385 | Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons |
Q33589580 | Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis |
Q50421305 | Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity |
Q34126949 | Pharmacology of signaling induced by dopamine D(1)-like receptor activation |
Q36205868 | Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. |
Q35798499 | Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. |
Q36211464 | Psychostimulants, madness, memory... and RGS proteins? |
Q36980901 | Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals. |
Q42949389 | Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions |
Q42933604 | Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine |
Q28589225 | Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating |
Q26852381 | Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models |
Q37925513 | Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. |
Q37336143 | Striatal plasticity and basal ganglia circuit function |
Q28396564 | Subcellular location of PKA controls striatal plasticity: stochastic simulations in spiny dendrites |
Q37424519 | Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia |
Q89701501 | The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia |
Q57176938 | The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery |
Q90049232 | The Neuroscience of Drug Reward and Addiction |
Q38099197 | The role of neuroplasticity in dopaminergic therapy for Parkinson disease. |
Q24650242 | Trace amine-associated receptor 1 as a monoaminergic modulator in brain |
Q28469044 | Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation |
Q34155012 | Treatment of the psychostimulant-sensitized animal model of schizophrenia. |
Q39035125 | What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome |
Search more.